Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,425.67 -12.98 (-0.15%) Bitcoin USD
66,765.06 +1,011.26 (+1.54%) CMC Crypto 200
1,360.79 -13.05 (-0.95%)
Chugai Pharmaceutical Co Ltd (CUP.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 08:24AM CEST. Market open.
| Previous close | 29.18 |
| Open | 29.18 |
| Bid | 29.21 x 100000 |
| Ask | 30.07 x 100000 |
| Day's range | 29.18 - 29.18 |
| 52-week range | 23.80 - 40.00 |
| Volume | |
| Avg. volume | 3 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's Why
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Is a Great Choice for 'Trend' Investors, Here's Why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
© 2024 Yahoo. All rights reserved.